Executive VP Jang Ji-hoon exercises stock purchase rights for 25,000 shares at 1,500 won (1.40% stake)
-
Executive Vice President Jang Ji-hoon acquired 25,000 common shares at 1,500 won per share on May 20, 2026 through exercise of stock purchase rights
-
Shareholding increased from 160,000 to 185,000 shares, raising ownership from 1.23% to 1.40%
-
Acquired shares are subject to a 1-year lock-up from listing date
KOSDAQ Filing Information
-
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
-
Company: Kanaph Therapeutics (0082N0)
-
Submission: Jang Ji-hoon
-
Receipt: 05-22-2026